The Privatization of Cancer
In my forthcoming article, I argue that our cancer regulatory regimes inadequately protect the public.

As has been proven time and again, “gut feeling” and wishful thinking have never been shown to replace controlled clinical testing.
COVID-19 highlights the importance of health policy change to socialize communicable disease costs, empower patients, and deregulate.